Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Romain Mazinghien"'
Autor:
Thierry Huet, Guy Dubreucq, Romain Mazinghien, Heidi Bompais, Loïc Vincent, Maurice Petitou, Arnaud Salvador, Jérôme Lemoine, Jan Balzarini, Cécile Gauchet, Olivier Querolle, Pascal Clayette, Dominique Schols, Bruno Lucidi, Olivier Kerbarh
Publikováno v:
Antimicrobial Agents and Chemotherapy. 54:134-142
Enfuvirtide (also known as Fuzeon, T-20, or DP-178) is an antiretroviral fusion inhibitor which prevents human immunodeficiency virus type 1 (HIV-1) from entering host cells. This linear 36-mer synthetic peptide is indicated, in combination with othe
Autor:
Patrick Hautefaye, Gilbert Lavielle, Sébastien Didier, Christian Bailly, Amélie Lansiaux, Alain Pierré, Marie-Hélène David-Cordonnier, Romain Mazinghien, Laurence Kraus-Berthier, Christine Bal-Mahieu, Stéphane Léonce, John A. Hickman
Publikováno v:
Molecular Pharmacology. 72:311-319
The E-ring lactone is the Achilles' heel of camptothecin derivatives: although it is considered necessary for the inhibition of the enzyme topoisomerase I (topo1), the opening of the lactone into a carboxylate abolishes the generation of topo1-mediat
Publikováno v:
European Journal of Pharmacology. 525:32-40
Sampangine is a plant-derived copyrine alkaloid extracted from the stem bark of Cananga odorata. This azaoxoaporphine alkaloid primarily exhibits antifungal and antimycobacterial activities but also displays in vitro antimalarial activity against Pla
Autor:
Marie-Hélène David-Cordonnier, Francois Tillequin, Thomas Gaslonde, Quyên Do, Bruno Pfeiffer, Sabine Depauw, Sylvie Michel, Rodrigue Yougnia, Alain Pierré, Michel Koch, Hanh Dufat, Wen Tian, Laurence Kraus-Berthier, Romain Mazinghien, Amélie Lansiaux, Stéphane Léonce
Publikováno v:
Bioorganicmedicinal chemistry. 17(5)
Monocinnamoyl esters at position 2 of (±)- cis -1,2-dihydroxy-6-methoxy-3,3,14-trimethyl-1,2,3,14-tetrahydro-7 H -benzo[ b ]pyrano[3,2- h ]acridin-7-one and their acetyl derivatives at position 1 were prepared as stabilized analogues of the anticanc
Publikováno v:
Anti-cancer drugs. 17(2)
Tafluposide (F11782), an epipodophyllotoxin derivative currently undergoing phase I clinical trials, is structurally close to the established anti-cancer drug etoposide, but mechanistically distinct. It is a dual inhibitor of topoisomerases I and II